V
Vasken Dilsizian
Researcher at University of Maryland, Baltimore
Publications - 297
Citations - 16086
Vasken Dilsizian is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Coronary artery disease & Positron emission tomography. The author has an hindex of 54, co-authored 282 publications receiving 14883 citations. Previous affiliations of Vasken Dilsizian include National Institutes of Health & University of Maryland Medical System.
Papers
More filters
Journal ArticleDOI
Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart
Manuel D. Cerqueira,Neil J. Weissman,Vasken Dilsizian,Alice K. Jacobs,Sanjiv Kaul,Warren K. Laskey,Dudley J. Pennell,John A. Rumberger,Thomas J. Ryan,Mario S. Verani +9 more
TL;DR: A remarkable committee was convened: The American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging came to an agreement upon all aspects of nomenclature and anatomic descriptions of the heart.
Journal ArticleDOI
Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging.
TL;DR: Data indicate that the reinjection of thallium improves the detection of ischemic myocardium and that myocardial regions with improvedThallium uptake on reinjection imaging represent viable but jeopardized myocardia.
Journal ArticleDOI
Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
TL;DR: Thallium imaging can be used to identify viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction and most irreversible defects with only mild or moderate reduction in thallium activity represent viableMyocardium as confirmed by FDG uptake.
Journal ArticleDOI
Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium.
Vasken Dilsizian,Robert O. Bonow +1 more
TL;DR: The accurate distinction between viable and scarred or necrotic myocardium has important clinical implications, especially in patients who are being considered for interventional therapy.
Journal ArticleDOI
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.
K. Lance Gould,Nils P. Johnson,Timothy M. Bateman,Rob S. Beanlands,Frank M. Bengel,Robert M. Bober,Paolo G. Camici,Manuel D. Cerqueira,Benjamin J.W. Chow,Marcelo F. Di Carli,Sharmila Dorbala,Henry Gewirtz,Robert J. Gropler,Philipp A. Kaufmann,Paul Knaapen,Juhani Knuuti,Michael E. Merhige,K.Peter Rentrop,Terrence D. Ruddy,Heinrich R. Schelbert,Thomas H. Schindler,Markus Schwaiger,Stefano Sdringola,John Vitarello,Kim A. Williams,Donald Gordon,Vasken Dilsizian,Jagat Narula +27 more
TL;DR: The basic concepts that hold true for whatever technology measures coronary physiology directly and reliably are clarified, here focusing on positron emission tomography and its interplay with intracoronary measurements.